In a separate study, mice bearing melanoma or sarcoma tumors and treated with broad spectrum antibiotics for 2 weeks were shown to have significantly worse survival with PD-1 and CTLA-4 blockade than mice not given antibiotics [63]. This evidence concerns the gene CTLA4 and melanoma.